• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Aquestive Therapeutics Inc (NQ: AQST )

    3.200 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 100
    Open 3.200
    Bid (Size) 3.110 (1)
    Ask (Size) 3.290 (6)
    Prev. Close 3.200
    Today's Range 3.200 - 3.200
    52wk Range 1.251 - 6.230
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows
    Aquestive Therapeutics released topline pharmacokinetic data for Anaphylm (epinephrine) Sublingual Film for severe allergic reactions. 
    Via Benzinga

    Performance

    YTD
    +59.20%
    +59.20%
    1 Month
    +25.00%
    +25.00%
    3 Month
    -26.94%
    -26.94%
    6 Month
    +27.49%
    +27.49%
    1 Year
    +106.45%
    +106.45%

    More News

    Read More
    Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    AQST Stock Earnings: Aquestive Therapeutics Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Aquestive Therapeutics to Report First Quarter 2024 Financial Results and Recent Business Highlights on May 7 and Host Conference Call on May 8 at 8:00 a.m. ET
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
    Via InvestorPlace
    Exposures Product Safety
    Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
    From Aquestive Therapeutics, Inc.
    Via GlobeNewswire
    Dow Surges 350 Points; Fed Holds Rates Steady
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Crude Oil Surges 2%; Signet Jewelers Shares Spike Higher
    Via Benzinga
    Topics Economy Stocks
    Exposures Fossil Fuels Interest Rates US Equities
    A Stock Split Catalyst Looms for Chipotle (CMG) Stock on June 6
    Via InvestorPlace
    INTC Stock Alert: Intel Just Got a Major $8.5 Billion Boost
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.